» Articles » PMID: 1286062

Interleukin 10 Inhibits Allogeneic Proliferative and Cytotoxic T Cell Responses Generated in Primary Mixed Lymphocyte Cultures

Overview
Journal Int Immunol
Date 1992 Dec 1
PMID 1286062
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

The effects of IL-10 on the generation of alloreactivity in primary mixed lymphocyte cultures (MLCs) were investigated. IL-10 inhibited in a dose-dependent fashion the alloantigen-induced proliferative responses. The suppressive effect was maximal when IL-10 was added at the beginning of the cultures, suggesting that it acts on the early stages of T cell activation. The proliferative responses were enhanced in the presence of a neutralizing anti-IL-10 mAb, indicating that endogenously produced IL-10 suppresses proliferation in primary MLC. The inhibitory effects of IL-10 were observed irrespective of whether irradiated allogeneic peripheral blood mononuclear cells, purified monocytes or freshly isolated B cells were used as stimulator cells. The proliferation of both the CD4+ and CD8+ T cell subsets was inhibited to a similar extent. The reduced proliferative responses were only minimally restored by high concentrations of exogenous IL-2, indicating that the effects of IL-10 are not exclusively due to inhibition of IL-2 synthesis. Furthermore, the production of IL-2, interferon (IFN)-gamma, IL-6, granulocyte macrophage colony stimulating factor, and tumor necrosis factor-alpha in primary MLCs was diminished by IL-10 and enhanced in the presence of anti-IL-10 mAb. The strongest effects were observed on the production of IFN-gamma. Although IL-10 reduces the proliferative responses, the ratios of CD3+CD4+ and CD3+CD8+ T cells remained the same in IL-10 treated and control cultures, yet the percentages of activated CD3+ T cells, as judged by CD25 and HLA-DR expression, were consistently reduced.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Engineered T Regulatory Type 1 Cells for Clinical Application.

Gregori S, Roncarolo M Front Immunol. 2018; 9:233.

PMID: 29497421 PMC: 5818395. DOI: 10.3389/fimmu.2018.00233.


A CB2-Selective Cannabinoid Suppresses T-Cell Activities and Increases Tregs and IL-10.

Robinson R, Meissler J, Fan X, Yu D, Adler M, Eisenstein T J Neuroimmune Pharmacol. 2015; 10(2):318-32.

PMID: 25980325 PMC: 4528965. DOI: 10.1007/s11481-015-9611-3.


Lung transplantation: infection, inflammation, and the microbiome.

Nakajima T, Palchevsky V, Perkins D, Belperio J, Finn P Semin Immunopathol. 2011; 33(2):135-56.

PMID: 21271250 DOI: 10.1007/s00281-011-0249-9.


Molecular and functional characterization of allogantigen-specific anergic T cells suitable for cell therapy.

Bacchetta R, Gregori S, Serafini G, Sartirana C, Schulz U, Zino E Haematologica. 2010; 95(12):2134-43.

PMID: 20713457 PMC: 2995573. DOI: 10.3324/haematol.2010.025825.


Increased interleukin-10 production and Th2 skewing in the absence of 5-lipoxygenase.

DiMeo D, Tian J, Zhang J, Narushima S, Berg D Immunology. 2007; 123(2):250-62.

PMID: 17894798 PMC: 2433306. DOI: 10.1111/j.1365-2567.2007.02694.x.